This trial is testing whether a drug called avatrombopag is safe and tolerated when given to people who have stopped taking eltrombopag or romiplostim.
- Idiopathic Thrombocytopenic Purpura (ITP)
1 Primary · 2 Secondary · Reporting Duration: Screening through Day 90 or End of Study
Awards & Highlights
0 Treatment Group
100 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 4
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Have any additional investigations been conducted regarding this treatment regimen?
"The initial research on this treatment was conducted at Dova Site in 2018, and since then there have been 19 similar trials that have concluded. Currently, 11 studies are actively recruiting participants with a majority of them based out of New Orleans, Louisiana." - Anonymous Online Contributor
Are there any openings remaining in this clinical research program?
"Going by the information on clinicaltrials.gov, this trial is currently in search of test subjects. It was originally published on March 15th 2021 and subsequently modified last November 1st 2022." - Anonymous Online Contributor
How many individuals are engaged in this research study?
"To complete this study, 100 volunteers fitting the established criteria must be recruited. These patients can register for participation at Sobi Site 124 in New Orleans and additionally at Sobi Site 125 in Saint Petersburg, Florida." - Anonymous Online Contributor
To what degree is this treatment hazardous for individuals?
"This medication has been approved for use and thus is given a score of 3 on the safety scale. This implies that phase 4 trials were conducted to confirm its efficacy and safety." - Anonymous Online Contributor
Is this trial a pioneering endeavor?
"Presently, 11 trials for this pharmaceutical are taking place in 78 cities and 11 countries. The initial study was conducted by Sobi Incorporated in 2018 with a population of 122 volunteers which successfully completed the Phase 3 clinical trial phase. 19 additional studies have been finalized since then." - Anonymous Online Contributor
How many venues are presently offering this research initiative?
"There are 36 centres offering this research opportunity, including Sobi Site 124 in New Orleans, Sobi Site 125 in Saint Petersburg and Sobi Site 126 in Peoria." - Anonymous Online Contributor